Abstract: The present invention is to a polyurethane dispersion and products produced therefrom wherein the dispersion contains a polyurethane prepolymer produced from the a reaction of an excess of a polyisocyanate with an isocyanate reactive molecule wherein the polyisocyanate is a bis(isocyanatomethyl)cyclohexane. Preferably the isocyanate comprises (i) trans-1,4-bis(isocyanatomethyl)cyclohexane or (ii) an isomeric mixture of two or more of cis-1,3-bis(isocyanatomethyl)cyclohexane, trans-1,3-bis(isocyanatomethyl)cyclohexane, cis-1,4-bis(isocyanatomethyl)cyclohexane and trans-1,4-bis(isocyanatomethyl)cyclohexane, with the proviso said isomeric mixture comprises at least about 5 weight percent of said trans-1,4-bis(isocyanatomethyl)cyclohexane.

Abstract: An aqueous binder dispersion that includes at least one copolymer (P) containing carboxylic acid and/or carboxylate groups. The copolymer (P) includes structural units of carboxyl-free (meth)acrylic esters with a cycloaliphatic structure, and at least 25 mol % of the carboxylic acid groups of the copolymer (P) in the dispersion being present in triethanolamine-neutralized form. The aqueous binder can be used in aqueous coating materials, which can be used to coat a substrate.

Abstract: The present invention provides synthetic polymers having novel catalytic functions which mimic enzymatic reactions. The invention also provides a method for measuring glycated proteins such as glycated hemoglobin (HbA1c) and glycated albumin and for measuring their decomposition products fructosylamines, such as fructosylvaline, as well as assay reagents and sensors for use in the method.

Abstract: A rubber composition includes ?,?-ethylenically unsaturated nitrile-conjugated diene copolymer rubber (A), ?,?-ethylenically unsaturated nitrile-conjugated diene copolymer rubber (B), ethylene-?-olefin copolymer rubber (C), and a graft copolymer (D). The graft copolymer (D) is obtained by performing graft copolymerization on a mixture of an aromatic vinyl compound and an ?,?-ethylenically unsaturated nitrite monomer with an ethylene-propylene-unconjugated copolymer. A content of structure units of the ethylene-propylene-unconjugated copolymer is 20 to 70 wt %, a ratio of the graft copolymer (D) with respect to 100 parts by weight in total of said rubber (A), rubber (B) and rubber (C) is 1 to 30 parts by weight. A composition ratio of the rubber (A), rubber (B) and rubber (C) is rubber (A): 20 to 79 wt %, rubber (B): 1 to 30 wt %, and rubber (C): 20 to 50 wt %.

Abstract: Disclosed is a method for making nongelled functional addition polymers from linear unsaturated anhydrides. The method subjects a linear unsaturated anhydride compound, an active hydrogen compound, and an epoxide compound to reaction conditions such that each of the following three reactions occur: (i) polymerization of polymerizable C?C bonds, (ii) ring opening of an anhydride functional group of the linear unsaturated anhydride compound by the active hydrogen compound to create an acid functional group, and (iii) reaction of the acid functional group resulting from the anhydride ring opening with the epoxide compound. At the time of reaction (iii), the acid functional group resulting from the anhydride ring opening may be selected from an ethylenically unsaturated monomer, a polymer, or both. In one embodiment, the method does not include the physical removal of any acid functional monomers or polymerization products. Also disclosed are a curable coating composition and a coated substrate.

Abstract: The present invention is a coupled radial anionic polymer comprising a polyhedral oligosilsesquioxane [POSS] of the formula [R—SiO3/2]n. POSS compounds having R=vinyl, glycidyldimethyl silyl, and isobutyl have been found effective in coupling anionic living polymers to yield radial polymers having 2 to 10 arms. Radial polymers of the present invention have been formed using POSS octamers and mixtures of POSS octamers, decamers and dodecamers. The present invention also relates to a process for coupling living anionic polymers with POSS compounds.

Abstract: A method is provided for making siloxane polycarbonate copolymers and blends of other polycarbonates with such copolymers wherein the copolymers and blends have excellent transparency and physical characteristic.

Abstract: An ethylene polymer composition having a density of at least 950 kg/m3, a fluidity index MI5 of 0.05 to 2 g/10 min and a content of alpha-olefin containing from 4 to 10 carbon atoms of from 0.15 to 1 mole %, containing from 53 to 63% by weight based on the total weight of the composition of an ethylene polymer fraction (A) having a fluidity index MI2 of at least 100 g/10 min a density of at least 969 kg/m3 and a molecular weight distribution Mw/Mn greater than 4, and from 37 to 47% by weight based on the total weight of the composition of a copolymer fraction (B) of ethylene and from 0.32 to 2.7 mole % of at least one alpha-olefin containing from 4 to 10 carbon atoms, a fluidity index MI5 to 0.001 to 0.5 g/10 min, a density of no more than 930 kg/m3 and a molecular weight distribution Mw/Mn greater than 4, wherein the ratio of the MI2 of fraction (A) to the MI5 of fraction (B) is greater than 20,000.

Abstract: There is provided a process for producing a vinyl chloride-based polymer, in which a suspension polymerization of either vinyl chloride monomer, or a mixture of vinyl chloride monomer and another copolymerizable monomer, is conducted in a polymerization vessel fitted with a reflux condenser, the process including the steps of: (A) adding to the reaction mixture a high-activity, oil-soluble polymerization initiator, with a 10-hour half life temperature of no more than 40° C. at a concentration of 0.1 mol/L in benzene, for a specified time within a period from the commencement of heat removal using the reflux condenser through to completion of the polymerization, and (B) adding an antioxidant either continuously or intermittently to the reaction mixture at least during the period from the commencement of addition of the high-activity, oil-soluble polymerization initiator through to completion of that addition.

Abstract: A polymerization process is provided. For example, a polymerization process is described, including providing a catalyst slurry having a metallocene catalyst and a first oil, providing a transport medium including a second oil and combining the transport medium and the catalyst slurry to form a catalyst mixture. The process may further include introducing the catalyst mixture to a polymerization reactor and contacting olefin monomers with the catalyst mixture to polymerize the olefin monomers and form polyolefins.

Abstract: A process for the preparation of a catalyst system includes the steps of combining a Lewis base, an organic compound having at least one functional group containing active hydrogen, and an organometallic component with a particulate support material to provide an intermediate composition, and then combining the intermediate composition with one or more metallocene compound. The catalyst system is advantageously used for olefin polymerization.

Abstract: Provided is a bridged cyclopentadienyl-dicarbollide complex having the formula of {L[(Cp)(C2B9R110)]}MR in which Cp is an unsubstituted, alkyl-substituted, aryl-substituted or fused ring cyclopentadienyl, R1 is hydrogen, or alkyl, L is a bridging unit that bonds to both Cp ring and cage carbon atoms, R is alkyl, aryl or a derivative thereof and M is Ti, Zr or Hf. A process for preparing the complex disclosed herein is also provided.

Abstract: Ethylene propylene copolymers, substantially free of diene, are described. The copolymers will have a uniform distribution of both tacticity and comonomer between copolymer chains. Further, the copolymers will exhibit a statistically insignificant intramolecular difference of tacticity. The copolymers are made in the presence of a metallocene catalyst.

Abstract: The invention provides for a process to produce polymers utilizing a hydrofluorocarbon diluent.

Abstract: A polycarboxylic acid cement dispersant that can exhibit high dispersing ability and allow deforming in early stages in the case of producing concrete products, whereby the turnover of a formwork is increased so as to improve productivity, and the method of producing such as concrete product are provided. The polycarboxylic acid cement dispersant which provides a cement composition having a penetration resistance value exponent of 55 MPa or more and a slump retention exponent of 80% or more, and the method of producing a concrete product which makes use of a copolymer derived by using monomer components comprising the monomer (A) as polyalkylene glycol unsaturated monomer, the monomer (B) as unsaturated carboxylic monomer, and the monomer (C) as sulfonic acid group-containing monomer.

Abstract: The interlayer insulating film of this invention is composed of a polymer in which a first monomer having four substituted acetylenyl groups and polymerizable in the three-dimensional direction and a second monomer having two substituted cyclopentanonyl groups and polymerizable in the two-dimensional direction are three-dimensionally polymerized.

Abstract: A comb-branched polymer is disclosed. The polymer comprises recurring units of an unsaturated carboxylic monomer, an oxypropylene-rich poly(oxyethylene-oxypropylene) macromonomer and an oxyethylene-rich poly(oxyethylene-oxypropylene) macromonomer. The comb-branched polymer can be used as a water reducing agent in cement. It gives significantly lower air entrainment in cement admixture.

Abstract: A phosphorus-containing urethane (meth)acrylate compound obtained by reacting (A) a polyol compound comprising (A1) a phosphorus-containing polyol having a phosphorus atom, with (B) a bifunctional or greater polyisocyanate and (C) a hydroxyl group-containing (meth)acrylate.

Abstract: A method and apparatus for synthesis of oligomeric cyclocarbonates from epoxy compounds and carbon dioxide in the presence of a catalyst. Star epoxy compounds and their preparation and use in making star cyclocarbonates, star hydroxy urethane oligomers, and star NIPU and HNIPU. Acrylic epoxy compounds, acrylic cyclocarbonates, acrylic hydroxy urethane oligomers, and acrylic NIPU and HNIPU and their methods of preparation.

Abstract: A process for the separation of volatile material from particulate polymer which has been substantially freed from unreacted monomer in an earlier separation step, comprising (a) feeding the particulate polymer to a purge vessel, optionally causing it to move through the vessel in substantially plug-flow mode, (b) heating the particulate polymer in the purge vessel to a temperature greater than 30° C. but insufficiently high to cause the particles to become agglomerated, and/or maintaining the polymer at a temperature in this range in the purge vessel, (c) feeding air to the purge vessel counter-current to the movement of the particulate polymer to remove volatile material therefrom, (d) removing the particulate polymer from the purge vessel. Preferably the particulate polymer fed to the purge vessel is caused to move through the vessel in substantially plug-flow mode. The process is particularly suitable for polyethylene.

Abstract: The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.

Abstract: There is disclosed movel mutant IGFBP-3 polypeptides and fragments thereof that have either no binding, or diminished binding to IGFs, yet retain their ability to bind to the human IGFBP-3 receptor (“P4.33”). The present invention provides novel mutant IGFBP-3 nucleic acid sequences, and expression systems. Additional embodiments provide for screening assays for identifying IGFBP-3 receptor antagonists or agonists, methods for modulating IGF-independent IGFBP-3 responses of cells expressing IGFBP-3 receptors, A methods for inducing or potentiating apoptosis of cells expressing IGFBP-3 receptors, methods for treating solid tumors having cells expressing IGFBP-3 receptors, and compositions comprising polypeptides having either no binding, or diminished binding to IGFs, yet retain their ability to bind to the IGFBP-3 receptor.

Abstract: A peptide, wherein the peptide is selected from the group consisting of Ser-Ser-Ser-Arg (SEQ ID NO: 1), Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro (SEQ ID NO: 4), Ser-Ser-Ser-Arg-Arg (SEQ ID NO: 5), Gly-Ser-Ser-Ser-Arg (SEQ ID NO: 6), Gly-Ser-Ser-Ser-Arg-Arg (SEQ ID NO: 7), Ala-Ser-Ser-Ser-Arg-Arg-Ala-Pro (SEQ ID NO: 8), Gly-Ser-Ser-Ser-Arg-Ala-Ala-Pro (SEQ ID NO: 9) and Gly-Ser-Ser-Ser-Arg-Ala-Ala-Ala-Pro (SEQ ID NO: 10), or a pharmaceutically acceptable salt thereof.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The growth hormone supergene family comprises greater than 20 structurally related cytokines and growth factors. A general method is provided for creating site-specific, biologically active conjugates of these proteins. The method involves adding cysteine residues to non-essential regions of the proteins or substituting cysteine residues for non-essential amino acids in the proteins using site-directed mutagenesis and then covalently coupling a cysteine-reactive polymer or other type of cysteine-reactive moiety to the proteins via the added cysteine residue. Disclosed herein are preferred sites for adding cysteine residues or introducing cysteine substitutions into the proteins, and the proteins and protein derivatives produced thereby.

Abstract: The present invention relates to a process for the production of fibres of an unhydroxylated recombinant collagen polypeptide, and the fibres obtained thereby, as well as to uses of such fibres as a biomaterial.

Abstract: The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognoses a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MART-1 melanoma antigen and a second melanoma antigen designated gp100. This invention further provides immunogenic peptides derived from the MART-1 melanoma antigen or gp100 antigen which have been modified to enhance their immunogenicity. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma.

Abstract: The present invention relates to improved antibodies against tumor surface antigens and their use in the treatment of tumors. Of particular interest are highly stable, humanized, high affinity antibodies against carcinoembryonic antigen (CEA), especially the antibody we have termed sm3E, which is derived from the scFv antibody MFE-23. Such antibodies have the potential for improved therapeutic efficacy.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The invention features a substantially pure DNA which includes a sequence encoding a novel steroid receptor co-activator which is overexpressed in breast cancer cells, diagnostic assays for steroid hormone-responsive cancers, and screening assays to identify compounds which inhibit an interaction of the co-activator with the steroid hormone.

Abstract: The subject invention provides a method for detecting the presence of human malignant cells in a sample of tumor cells, which comprises contacting the sample with an antibody directed to an epitope present on the ? subunit of human luteinizing hormone or on intact human luteinizing hormone under conditions such that the antibody forms a complex with cells present in the sample if the epitope is present on the surface of the cells, and determining whether the antibody forms such a complex. The subject invention also provides a method for determining whether a tumor present in a human subject is malignant which comprises obtaining a sample of cells from the tumor and detecting the presence of malignant cells in the sample according to the method of the subject invention.

Abstract: The present invention is directed to novel antibodies that bind to novel polypeptides encoded by nucleic acids that are differentially expressed in lung, stomach, and melanoma tumors.

Abstract: The present invention provides compositions and methods for selectively inhibiting the proliferation of stellate cells, which are important for the development of liver fibrosis upon liver injury. The invention describes conditioned media from immortalized hepatocytes as containing a death factor that induces apoptosis of activated liver stellate cells. This pro-apoptotic activity is shown to be associated with an 80 kDa protein, which is associated with a fetuin peptide sequence and an albumin peptide sequence.

Abstract: Methods for the production of recombinant peptides comprise fermenting cells to produce recombinant peptides. A metal salt is added to a concentrate of the fermented cells after the fermentation step, prior to peptide isolation, and the pH of the cell concentrate after the addition of the metal salt is less than or equal to 7, thereby reducing the amount of trifulsides formed in the production of the recombinant peptide, with the proviso that the production does not include conversion of formed trifulside peptide into native peptide form after the addition of the metal salt. In one embodiment, the recombinant peptide is recombinant growth hormone.

Abstract: The present invention relates to a disazo red reactive dyestuff containing quaternary ammonium group of the following formula (1): wherein R?, R?, m, n, Y1 and Y2 are defined the same as in the specification. The disazo red reactive dyestuff of the present invention has a good dye uptake while dyeing cellulose fibers, which satisfies the economical demand of high build up in the market.

Abstract: A colorant for ocular lenses represented by the formula (I) defined herein or a colorant for ocular lenses represented by the formula (II) defined herein.

Abstract: Disclosed herein are compositions and methods used to modulate a NH2-terminal Jun Kinase activity. These compositions and methods can be employed to regulate metabolic disorders associated with, for example, insulin such as diabetes. The reduction in NH2-terminal Jun Kinase activity can lead to the reduction in weight and improve insulin sensitivity.

Abstract: The invention provides methods and materials related to expressing chimeric IgE proteins. Specifically, the invention provides nucleic acid vectors, host cells, and methods for producing chimeric IgE polypeptides.

Abstract: The present invention relates to methods for gene therapy, especially to adenovirus-based gene therapy, and related cell lines and compositions. In particular, novel nucleic acid constructs and packaging cell lines are disclosed, for use in facilitating the development of high-capacity and targeted vectors. The invention also discloses a variety of high-capacity adenovirus vectors and related compositions and kits including the disclosed cell lines and vectors. Finally, the invention discloses methods of preparing and using the disclosed vectors, cell lines and kits.

Abstract: This invention relates to processes for production of alkylamino glucosaminide phosphate compounds, and of disaccharide compounds, including various novel intermediates and intermediate processes. In one aspect, glycosyl halides are produced by reaction of an O-silyl glycoside with a dihalomethyl alkyl ether.

Abstract: Described herein is at least one pyrrolo[1,2-f][1,2,4]triazine-2,4(1H,3H)-dione, which is an intermediates useful in preparing 2,4-disubstituted pyrrolotriazine compounds, and at least one method for making such intermediate.

Abstract: The invention relates to a process for the preparation of certain pyrimidinone compounds.

Abstract: A process for preparing quinazolin-4-one or its derivative by reacting anthranilic acid or its derivative with formic acid or its derivative in the presence of ammonia, or by reacting ammonium anthranilate or its derivative with formic acid or its derivative.

Abstract: Novel crystals of a potassium salt of (E)-N-[6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]-2-phenylethenesulfonamide, a preparation process thereof, and novel solvates of (E)-N-[6-methoxy-5-(2-ethoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]-2-phenylethenesulfonamide.

Abstract: The present invention provides a process for the preparation of substituted dihydropyrimidinones using polyaniline salts as reusable catalysts, which comprises reacting an aldehyde, a ?-keto ester and urea/thiourea in the presence of a polyaniline salt catalyst and separating the substituted dihydropyrimidinone obtained.

Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.

Abstract: A process for the production of naphthyridine-3-carboxylic acid derivatives of formula (I) having antibacterial activity.

Abstract: The present invention relates to a process for the production of piperidine derivatives with microorganisms. This is carried out by incubating starting compounds in the presence of a microorganism under conditions effective to produce piperidine derivative products. Suitable microorganisms can be from any one of the genus of Stemphylium, Gliocladium, Bacillus, Botrytis, Cyathus, Rhizopus, Pycniodosphora, Pseudomonas, Helicostylum, Mucor, Gelasinospora, Rhodotorula, Candida, Mycobacterium, and Penicillium. In another aspect of the invention, starting compounds are incubated in the presence of Cunninghamella bainieria under conditions effective to produce piperidine derivative products.

Abstract: This invention is to provide a process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs and salts thereof, comprising the reaction shown by the following scheme. The ester analogs can be prepared in one pot, and in good yield by using tertiary alkyl cyanoacetate. Furthermore, the method is useful for preparing derivatives of various analogs of the ester, e.g. alkyl substituted and aryl substituted analogs.

Abstract: The present invention relates to methods for preparing indazole compounds of formula I, which are useful as modulators and/or inhibitors of protein kinases. The present invention also relates to intermediate compounds useful in the preparation of compounds of formula I.